Iparomlimab is a monoclonal IgG4?? antibody that targets the human programmed death-1 receptor (PD-1, also known as CD279 or PDCD1). This antibody is engineered to bind specifically to the PD-1 receptor, a critical molecule involved in the negative regulation of immune responses and a key therapeutic target in oncology. Iparomlimab is composed of a ??4-chain and a ??-chain of the human monoclonal antibody PSB103, linked by a disulfide bond to form a stable dimer. This biologic is primarily utilized in research focused on cancer immunotherapy, investigating the modulation of immune checkpoints that are pivotal in tumor immune evasion.
Iparomlimab is a monoclonal IgG4?? antibody that targets the human programmed death-1 receptor (PD-1, also known as CD279 or PDCD1). This antibody is engineered to bind specifically to the PD-1 receptor, a critical molecule involved in the negative regulation of immune responses and a key therapeutic target in oncology. Iparomlimab is composed of a ??4-chain and a ??-chain of the human monoclonal antibody PSB103, linked by a disulfide bond to form a stable dimer. This biologic is primarily utilized in research focused on cancer immunotherapy, investigating the modulation of immune checkpoints that are pivotal in tumor immune evasion.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
